ALB:NYE-Albemarle Corporation (USD)

COMMON STOCK | Specialty Chemicals | NYE

Last Closing Price

USD 231.75

Change

-4.41 (-1.87)%

Market Cap

USD 27.62B

Volume

1.14M

Avg Analyst Target

USD 220.11 (-5.02%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine Specialties segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-10-27 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LIN Linde plc

+2.20 (+0.69%)

USD163.54B 50.78 18.62
SHW The Sherwin-Williams Company

+1.36 (+0.43%)

USD83.21B 39.58 25.20
ECL Ecolab Inc

-9.18 (-3.99%)

USD65.88B 63.21 28.02
PPG PPG Industries Inc

-0.35 (-0.22%)

USD38.43B 27.20 17.65
DD DuPont de Nemours Inc

-2.78 (-3.86%)

USD37.62B 7.79 10.59
IFF International Flavors & Fragra..

+0.17 (+0.11%)

USD36.99B 33.42 43.88
LYB LyondellBasell Industries N.V

-3.19 (-3.27%)

USD32.66B 7.99 7.18
AVTR Avantor Inc

-0.77 (-2.04%)

USD22.92B 83.22 31.52
AVTR-PA Avantor Inc

-2.25 (-1.94%)

USD19.08B 256.27 N/A
WLK Westlake Chemical Corporation

-7.04 (-6.84%)

USD13.18B 14.21 6.98

ETFs Containing ALB

Symbol Name Weight Mer Price(Change) Market Cap
GNRX VanEck Vectors Generic Dr.. 0.00 % 0.55 %

N/A

USD3.35M
IYM iShares U.S. Basic Materi.. 0.00 % 0.43 %

-3.62 (-2.66%)

USD1.18B
LIT Global X Funds - Global X.. 0.00 % 0.75 %

-0.41 (-0.45%)

USD3.64B
PYZ Invesco DWA Basic Materia.. 0.00 % 0.60 %

-2.90 (-3.16%)

USD0.22B
QCLN First Trust NASDAQ Clean .. 0.00 % 0.60 %

+1.34 (+1.88%)

USD2.81B
MID American Century Mid Cap .. 0.00 % 0.45 %

+0.06 (+0.09%)

N/A
CHRG:LSE WisdomTree Battery Soluti.. 0.00 % 0.40 %

+30.50 (+0.79%)

N/A
ELCR:XETRA Lyxor Index Fund - Lyxor .. 0.00 % 0.15 %

+0.01 (+0.05%)

USD0.30B
VOLT:LSE WisdomTree Battery Soluti.. 0.00 % 0.40 %

+0.32 (+0.60%)

N/A
QCLU:LSE First Trust Nasdaq® Clea.. 0.00 % 0.75 %

+0.25 (+0.90%)

N/A
HLIT:CA Horizons Global Lithium P.. 0.00 % 0.00 %

-0.68 (-1.78%)

N/A
ELCR:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
SPRX Spear Alpha ETF 0.00 % 0.75 %

-0.30 (-1.41%)

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 57.10% 95% A 90% A-
Dividend Return 0.79% 19% F 18% F
Total Return 57.89% 95% A 90% A-
Trailing 12 Months  
Capital Gain 155.29% 98% A+ 93% A
Dividend Return 1.71% 38% F 28% F
Total Return 157.00% 98% A+ 93% A
Trailing 5 Years  
Capital Gain 179.52% 100% A+ 89% B+
Dividend Return 8.57% 30% F 25% F
Total Return 188.09% 100% A+ 89% B+
Average Annual (5 Year Horizon)  
Capital Gain 26.01% 80% B- 86% B
Dividend Return 1.64% 43% F 39% F
Total Return 27.65% 80% B- 86% B
Risk Return Profile  
Volatility (Standard Deviation) 63.93% 23% F 13% F
Risk Adjusted Return 43.25% 60% D- 48% F
Market Capitalization 27.62B 83% B 90% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 37.34 25% F 20% F
Price/Book Ratio 4.39 27% F 24% F
Price / Cash Flow Ratio 34.57 10% F 11% F
EV/EBITDA 24.35 15% F 21% F
Management Effectiveness  
Return on Equity 14.82% 57% F 64% D
Return on Invested Capital 5.97% 45% F 59% F
Return on Assets 3.44% 22% F 60% D-
Debt to Equity Ratio 61.93% 63% D 55% F
Technical Ratios  
Short Ratio 1.41 93% A 64% D
Short Percent 1.65% 66% D 69% D+
Beta 1.59 37% F 21% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.